© Copyright by HealthHelpZone.com. All rights reserved.
LOS ANGELES, Oct. 25, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its third quarter 2024 financial results on Monday, November 11, 2024 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are... ❯❯❯
New funding will support strategic expansion of PeopleOne Health, improving access to preventive care and treatment to keep people healthier throughout communities in the U.S.PITTSBURGH, Oct. 24, 2024 (GLOBE NEWSWIRE) -- PeopleOne Health, a pioneer in value-based primary care, today announced the close of up to $32.3 million Series B funding, led by GV (Google Ventures), with participation from other notable investors including... ❯❯❯
"Robotic Heart Surgery" at KFSHRC…A Leading and Accelerating Journey of Success RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) continues to set itself apart by providing innovative specialized healthcare services, particularly through its robotic heart surgery program which has experienced accelerated success since its establishment in 2019. In its first year, the... ❯❯❯
Novel Technique Hopes to Extend Robotic Transplant to More Patients RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has achieved another world first by performing a fully robotic left lobe liver transplant from a living donor. The novel technique led by Prof. Dieter Broering, the Executive Director of the Organ Transplant Center of Excellence, promises all the... ❯❯❯
Funding to support blueprint for new high-quality, innovative models of care in Canada and beyondTORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Canadians take great pride in their universal healthcare system, but with emergency rooms overwhelmed, a shortage of family doctors, an aging population, and hallway medicine at an all-time high, the system is at a critical crossroads. In response, today, Humber River Health Foundation (HRHF)... ❯❯❯
Predicting Healthcare Demand RIYADH, Saudi Arabia, Oct. 23, 2024 (GLOBE NEWSWIRE) -- World-class medical institutions are striving to find sustainable health innovations to maintain top healthcare services, address operational challenges, and manage potential crises. The Patient Flow & Capacity Command Centre at King Faisal Specialist Hospital & Research Centre (KFSHRC) serves as a leading model in enabling AI-driven healthcare... ❯❯❯
7,400+ Stem Cell Transplants Performed RIYADH, Saudi Arabia, Oct. 22, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) celebrated the 40th anniversary of its Stem Cell program, a regional leader in bone marrow and stem cell transplantation. Ranked within the top 2% facilities worldwide for the volume of annual stem cell transplants, the Centre had successfully performed more than 7,400 transplants... ❯❯❯
With a large attendance of health leaders and experts from around the world RIYADH, Saudi Arabia, Oct. 22, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) celebrated the recognition of 28 of its scientists in Stanford University's list of the top 2% of the most-cited researchers globally across various disciplines over the past year. This event, attended by a significant number of health leaders... ❯❯❯
Solidifying its Leading Role in Providing Innovative Solutions for Kidney Failure Patients RIYADH, Saudi Arabia, Oct. 22, 2024 (GLOBE NEWSWIRE) -- In a step that solidifies its position as a leading healthcare institution regionally and internationally, King Faisal Specialist Hospital and Research Centre (KFSHRC) celebrated its success in performing 500 paired kidney transplants since the inception of its Kidney Paired Donation... ❯❯❯
European Patent Office to grant a patent for DRP® companion diagnostic for Allarity’s stenoparib cancer therapy Patent applications for the Stenoparib DRP® are also pending in the US, Japan, China, Australia, and India Boston (October 22, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments using its proprietar... ❯❯❯